Neuroprotective effects of early antiretrovirals in vertical HIV infection
Abstract
We performed a retrospective study of a series of 58 of 189 vertically HIV-1 infected children who went on to develop progressive HIV-1-associated encephalopathy to assess real-life effects of early antiretroviral therapy on neurologic outcome. Our findings clearly indicate that antiretroviral therapy before the onset of neurologic symptoms delayed presentation of progressive HIV-1-associated encephalopathy, with an additional beneficial effect on survival.
Keywords: CNS, HIV-1-related encephalopathy, development, pediatric AIDS, survival, viral load
To access this article, please choose from the options below
PII: S0887-8994(03)00210-8
doi:10.1016/S0887-8994(03)00210-8
© 2003 Elsevier Inc. All rights reserved.
